The overlap of biologics during medication switches is common in routine care of patients with IBD and isn’t linked to a ...

A clinical trial co-led by the Hospital for Special Surgery (HSS) has found that blocking inflammation with the drug ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

EnviroBiotics, the leader in bio-based indoor purification, announced the launch of two revolutionary products: the E-Biotic ...

President Donald Trump wants Congress to change a policy that gives certain drugs longer protection from drug price negotiations in Medicare, a fix that could address one of the drug industry’s top ...

Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate response or intolerable adverse events. Evidence from observational studies and ...

A RECENT study has highlighted key biological and clinical factors linked to resistance to biologic therapies in patients ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...

Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...